40 mm以下散发性肾血管平滑肌脂肪瘤的监测影像:一家大型地区综合医院的经验教训与建议
研究纳入2009年9月至2015年3月诊断的217个散发性肾血管平滑肌脂肪瘤,中位随访24个月,中位诊断尺寸9.00 mm,平均生长率0.13 mm/年;69%无生长或负增长,多因素分析显示肿瘤大小、肿瘤负荷和年龄与更高生长率无关。作者本院做法是对大于20 mm者进行监测,21-29 mm每五年超声检查,30-39 mm每两年监测。
要点
- 多数散发性肾血管平滑肌脂肪瘤较小且不生长,69%表现为负增长或零增长。
- 本研究中心的做法是仅对大于20 mm的散发性肾血管平滑肌脂肪瘤进行监测。
- 21-29 mm者每五年行超声扫描,30-39 mm者每两年监测。
核心结论
- 大多数散发性肾血管平滑肌脂肪瘤较小且不生长;肿瘤大小、肿瘤负荷和年龄在多因素分析中与更高生长率无关;作者据本院经验提出按肿瘤大小分层的监测方案。
研究设计与样本
- 回顾性纳入2009年9月至2015年3月诊断的217个散发性肾血管平滑肌脂肪瘤,排除结节性硬化症患者,中位随访24个月(范围10-118个月)。
诊断标准与关键数值
- 诊断时中位大小为9.00 mm,平均生长率为0.13 mm/年(标准差0.88)。
- 150个血管平滑肌脂肪瘤(69%)表现为负增长或零增长。
- 其余67个中,59个生长率小于2.00 mm/年。
- 多因素分析显示血管平滑肌脂肪瘤大小、肿瘤负荷和年龄与更高生长率无关。
临床应用与阅片要点
- 本研究中心的做法是对大于20 mm的散发性肾血管平滑肌脂肪瘤进行监测。
- 本研究中心的做法是对21-29 mm的肿瘤每五年行超声扫描。
- 本研究中心的做法是对30-39 mm的肿瘤每两年监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Introduction Sporadic renal angiomyolipomas, although benign in natural can cause life-threatening spontaneous haemorrhage. Surveillance of smaller lesions is recommended but there is no guidance on the surveillance interval or modality. Our aim was to study our sporadic angiomyolipoma population to determine the growth rate, factors that were associated with a higher growth rate and design a surveillance programme. Materials and methods All sporadic renal angiomyolipomas diagnosed between September 2009 and March 2015 were included. Patients with a diagnosis of tuberous sclerosis were excluded. Results A total of 217 sporadic renal angiomyolipomas were diagnosed. The median follow-up was 24 months (range 10-118 months). The median size at diagnosis was 9.00 mm with a mean growth rate of 0.13 mm/year (standard deviation 0.88). One hundred and fifty angiomyolipomas (69%) were shown to have negative or zero growth. In the remaining 67, 59 had a growth rate of less than 2.00 mm/year. Size of angiomyolipoma, tumour burden and age were not associated with a higher growth rate on multivariate analysis. Conclusion The majority of sporadic angiomyolipomas are small and do not grow. Our practice is to perform surveillance for those greater than 20 mm, with five-yearly ultrasound scans for 21-29 mm, and two-yearly surveillance for 30-39 mm tumours.
引用
- Chan KE, Chedgy E, Bent CL, et al. Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital. Ann R Coll Surg Engl. 2018. PMID: 29658337. doi:10.1308/rcsann.2018.0040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。